The p110α isoform of PI3K is essential for proper growth factor signaling and oncogenic transformation
- 31 October 2006
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 103 (44), 16296-16300
- https://doi.org/10.1073/pnas.0607899103
Abstract
Growth factor signaling is mediated through Class IA phosphatidylinositol 3-kinases (PI3Ks). Among this class of enzymes, only p110α, encoded by the PIK3CA gene, has been found to be mutant in human cancers. To determine the specific functions of p110α, we generated mice carrying a conditionally targeted allele of the PIK3CA gene. Here, we report that PIK3CA-knockout mouse embryonic fibroblasts are deficient in cellular signaling in response to various growth factors, unable to differentiate into adipocytes, and resistant to oncogenic transformation induced by a variety of oncogenic receptor tyrosine kinases, indicating a fundamental role for p110α in these biological processes.Keywords
This publication has 28 references indexed in Scilit:
- A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin SignalingCell, 2006
- Essential role for the p110δ phosphoinositide 3-kinase in the allergic responseNature, 2004
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- PHOSPHOINOSITIDE KINASESAnnual Review of Biochemistry, 1998
- p110δ, a Novel Phosphatidylinositol 3-Kinase Catalytic Subunit That Associates with p85 and Is Expressed Predominantly in LeukocytesJournal of Biological Chemistry, 1997
- Role of Phosphoinositide 3-OH Kinase in Cell Transformation and Control of the Actin Cytoskeleton by RasCell, 1997
- p110δ, a novel phosphoinositide 3-kinase in leukocytesProceedings of the National Academy of Sciences, 1997
- CORRELATION OF C-ERBB-2-GENE AMPLIFICATION AND PROTEIN EXPRESSION IN HUMAN-BREAST CARCINOMA WITH NODAL STATUS AND NUCLEAR GRADING1988
- Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185Cell, 1986
- Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenesNature, 1983